Learn Mode

MEDP - Medpace Holdings Inc

229

$459.96

$8.76 (1.941%)

3/30/26, 6:28 PM

Score

3.86/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

MEDP

Valuation Score

View as %

Stock Unlock

YTD

Max

Stock Profile

Market Cap

$13.13B

Industry

Life Sciences Tools & Services

EPS (TTM)

$15.56

P/E (TTM)

29.10

Div & Yield

FCF Payout Ratio

P/S (TTM)

5.19

P/B

28.60

Diluted Shares

28.98M

Ex-Dividend

Next Earnings

04-22

Forward P/E

26.37

Payout Ratio

P/FCF (TTM)

19.25

FCF Yield

5.19%

Earnings Yield

3.44%

52 Week Range

Score Card

Explore Scores Tab

3.86

Good

Medpace Holdings Inc has grown revenue at 19.97% over the past year, which is strong growth. Also, it has a free cash flow margin of 26.95%, which suggests the company is very profitable.

Valuation Model

Key Score

3.00

Average

Management

4.00

Good

Growth

3.00

Average

Profitability

5.00

Very Good

Fin. Health

4.00

Good

Dividends

Analyst

1.00

Very Bad

Insider Transactions

Explore Insider Tab

Buy

Sell

Market News

Page 1 of 21

1 new filing was in the last 7 days

Filter Form Types

Form SCHEDULE 13G/A

Unknown Form Type

Filed on 2026-03-27 10:33:41

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-19 16:50:47

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-19 16:45:41

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-03-17 12:37:52

Form PRE 14A

Unknown Form Type

Filed on 2026-03-16 17:23:12

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-02-18 16:59:18

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-02-17 16:59:21

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-02-17 16:43:08

Form 10-K

Annual financials report pursuant to Section 13 or 15(d)

Filed on 2026-02-10 16:03:32

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-02-09 16:15:22

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-01-05 16:24:40

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-01-05 16:18:08

Page 1 of 21

Financials

Explore Financials Tab

Revenue

Earnings

Free Cash Flow

Price Targets

Go to Analyst Tab

These are one year price targets for: 2027-02-21

High:

$611.10

32.9%

Avg:

$497.46

8.2%

Low:

$341.82

-25.7%

(% change is relative to the current stock price: $459.96)

Analyst Recommendations

Go to Analyst Tab

3.53

Good

21%

Strong Buy (4)

21%

Buy (4)

47%

Hold (9)

11%

Sell (2)

Strong Sell (0)

About

Website
https://investor.medpace.com/
Address
5375 Medpace Way, Cincinnati OHIO, US
SEC Reports
https://sec.gov/edgar/browse/?CIK=1668397

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company is headquartered in Cincinnati, Ohio and currently employs 5,900 full-time employees. The company went IPO on 2016-08-11. The firm partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company’s drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The firm also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company’s operations are principally based in North America, Europe, and Asia.

IPO Date

2016-08-11

Industry

Life Sciences Tools & Services

Total Employees

5,900

Exchange

Nasdaq Nms - Global Market

Reporting Currency

USD

GICS

Life Sciences Tools & Services

GICS Sub

Life Sciences Tools & Services

GICS Sector

Health Care

GICS Group

Pharmaceuticals, Biotechnology & Life Sciences

MEDP - Medpace Holdings Inc

229

$459.96

$8.76 (1.941%)

3.86/5

Stock Unlock

Stock Profile

Score Card

Good

Insider Transactions

Market News

Form SCHEDULE 13G/A

Filed on 2026-03-27 10:33:41

Form 4

Filed on 2026-03-19 16:50:47

Form 4

Filed on 2026-03-19 16:45:41

Form 144

Filed on 2026-03-17 12:37:52

Form PRE 14A

Filed on 2026-03-16 17:23:12

Form 4

Filed on 2026-02-18 16:59:18

Form 4

Filed on 2026-02-17 16:59:21

Form 4

Filed on 2026-02-17 16:43:08

Form 10-K

Filed on 2026-02-10 16:03:32

Form 8-K

Filed on 2026-02-09 16:15:22

Form 4

Filed on 2026-01-05 16:24:40

Form 4

Filed on 2026-01-05 16:18:08

Financials

Price Targets

32.9%

8.2%

-25.7%

Analyst Recommendations

About

Similar Stocks